|
2025
|
Invention
|
Polycyclic pyridone derivative and use thereof. The present invention provides a polycyclic pyrid... |
|
|
Invention
|
Nucleic acid molecule inhibiting f11 gene expression. The present invention relates to a nucleic ... |
|
2024
|
Invention
|
Crystal form of compound containing tricyclic heteroaryl, and preparation method therefor and use... |
|
|
Invention
|
Amide derivative, preparation method therefor and use thereof. The present invention provides an ... |
|
|
Invention
|
Drugs for combined use in treating tumor. Provided are a pharmaceutical combination comprising a ... |
|
|
Invention
|
Dsrna molecule for inhibiting expression of complement masp2 gene and use thereof. Provided are a... |
|
|
Invention
|
Ttr-targeted gene editing composition. The application relates to a composition and method for TT... |
|
|
Invention
|
Efficient, low off-target gene editing tool. The invention relates to a gene editing tool having ... |
|
|
Invention
|
Egfr degradant, and preparation method and use therefor. As shown in formula (I), a bifunctional ... |
|
|
Invention
|
Antisense oligonucleotide for inhibiting trpv1 gene expression and use thereof. Provided are an a... |
|
|
Invention
|
Dsrna molecule for inhibiting sod1 gene expression and use thereof. Provided are a modified doubl... |
|
|
Invention
|
Dsrna molecule inhibiting hbv gene expression and use thereof. Provided are a dsRNA molecule inhi... |
|
|
Invention
|
Polycyclic compound and use thereof. Provided are a compound represented by formula (I'), or a ta... |
|
|
Invention
|
Compound for treating and preventing respiratory syncytial virus infection diseases. Provided are... |
|
|
Invention
|
Rnai agent for inhibiting agt gene expression and use thereof. The present invention relates to a... |
|
|
Invention
|
Dsrna molecule for inhibiting lp(a) gene expression and use thereof. Disclosed are a modified dsR... |
|
|
Invention
|
Use of heterocyclic anti-tumor compound. The invention relates to the technical field of medicine... |
|
|
Invention
|
Crystal form of enpp1 inhibitor. Provided in the present application are a compound as represente... |
|
|
Invention
|
Use of pharmaceutical composition comprising mitoxantrone liposome and cytarabine in the treatmen... |
|
|
Invention
|
Nucleic acid lipid nanoparticle with low no-load rate and preparation method therefor. A lipid na... |
|
|
Invention
|
Dsrna molecule for inhibiting c5 gene expression, and use thereof. Provided are a modified dsRNA ... |
|
|
Invention
|
Use of paclitaxel cationic liposome in treating tumors. The present invention provides a use of a... |
|
|
Invention
|
Modified nucleoside monomer and double-stranded ribonucleic acid. The present invention relates t... |
|
|
Invention
|
Cdk inhibitor and crystal form of pharmaceutically acceptable salt thereof, and use thereof. Prov... |
|
2023
|
Invention
|
Use of cdk inhibitor. Provided is the use of a CDK inhibitor compound A in the preparation of an ... |
|
|
Invention
|
Salt and crystal form of anti-tumor heterocyclic compound. Provided are a crystal form of a free ... |
|
|
Invention
|
Amine compound and use thereof. CC, L, R1, R2, and n in formula (I) are as defined in the specifi... |
|
|
Invention
|
Use of mitoxantrone liposome in combination with capecitabine in treating nasopharyngeal carcinom... |
|
|
Invention
|
Use of compound containing tricyclic heteroaryl. Provided is use of a JAK and SYK kinase inhibito... |
|
|
Invention
|
Use of mitoxantrone hydrochloride liposome. The present application provides a use of mitoxantron... |
|
|
Invention
|
Anti-tumor paclitaxel compound. Provided is an anti-tumor paclitaxel compound. Specifically, prov... |
|
|
Invention
|
Tricyclic compounds and uses thereof. The present invention provides a class of compounds represe... |
|
|
Invention
|
Pharmaceutical combination and pharmaceutical composition for treating cancer. Provided are a pha... |
|
|
Invention
|
Compound having liver-targeting delivery effect and oligonucleotide conjugate thereof. The presen... |
|
|
Invention
|
Instant nanoparticle composition and preparation method therefor.
A nanoparticle composition for... |
|
|
Invention
|
Instant nanoparticle composition and preparation method therefor. An instant nanoparticle composi... |
|
|
Invention
|
Crystalline form of fgfr4 inhibitor and use thereof.
A crystalline form of an FGFR4 inhibitor an... |
|
|
Invention
|
Use of mitoxantrone liposome in combination with anti-angiogenic targeted drug for treating ovari... |
|
|
Invention
|
Crystal form of fgfr4 inhibitor and use thereof. The present invention relates to a crystal form ... |
|
2022
|
Invention
|
Heterocyclic compound having anti-tumor activity and use thereof.
Provided are a class of compou... |
|
|
Invention
|
Salt of 3,4-dihydroisoquinoline compound and use thereof.
Provided are a salt of a compound repr... |
|
|
Invention
|
Use of mitoxantrone hydrochloride liposome in preparation of drugs for treating advanced solid tu... |
|
|
Invention
|
Spiro compound and use thereof.
Provided in the present invention are a class of compounds as re... |
|
|
Invention
|
Use of mitoxantrone hydrochloride liposome.
Provided is a use of a mitoxantrone hydrochloride li... |
|
|
Invention
|
Use of a compound containing a tricyclic heteroaryl group.
The present application provides use ... |
|
|
Invention
|
Stable docetaxel albumin nanoparticle composition.
A composition containing a docetaxel albumin ... |
|
2021
|
Invention
|
Pharmaceutical composition of multi-target protein kinase inhibitors, and use thereof.
A pharmac... |
|
|
Invention
|
Use of mitoxantrone hydrochloride liposome.
The present application provides a use of mitoxantro... |
|
|
Invention
|
A class of fused ring compounds, and preparation and use thereof.
The present invention belongs ... |
|
|
Invention
|
Use of mitoxantrone hydrochloride liposome and cyclophosphamide, vincristine and prednisone.
The... |
